Download PDF
Nuklearmedizin 2012; 51(01): N10-N11
DOI: 10.1055/s-0037-1621959
Case report
Schattauer GmbH

Early dynamic PET imaging shows hypervascularization as exact as contrast-enhanced MR

M. Freesmeyer
1   Clinic of Nuclear Medicine, University Hospital Jena
,
E. Lopatta
2   Institute of Diagnostic and Inter – ventional Radiology, University Hospital Jena
,
J.-H. Schierz
1   Clinic of Nuclear Medicine, University Hospital Jena
,
J. Steenbeck
1   Clinic of Nuclear Medicine, University Hospital Jena
,
T. Opfermann
1   Clinic of Nuclear Medicine, University Hospital Jena
,
U. Settmacher
3   Clinic of General, Visceral and Vascular Surgery, University Hospital Jena, Germany
› Author Affiliations
Further Information

Publication History

received: 13 November 2011

accepted in revised form: 10 January 2012

Publication Date:
09 January 2018 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Ayyappan AP, Jhaveri KS. CT and MRI of hepatocellular carcinoma: an update. Expert Rev Anticancer Ther 2010; 10: 507-519.
    CrossrefPubMedGoogle Scholar
  • 2 Donati OF, Reiner CS, Hany TF. et al. 18F-FDG-PET and MRI in patients with malignancies of the liver and pancreas. Accuracy of retrospective multimodality image registration by using the CT-component of PET/CT. Nuklearmedizin 2010; 49: 106-114.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Hain SF, Fogelman I. Recent advances in imaging hepatocellular carcinoma: diagnosis, staging and response assessment: functional imaging. Cancer J 2004; 10: 121-127.
    CrossrefPubMedGoogle Scholar
  • 4 Kim TK, Lee KH, Khalili K, Jang HJ. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. Abdom Imaging 2011; 36: 244-263.
    CrossrefPubMedGoogle Scholar
  • 5 Kotzerke J, Oehme L, Lindner O, Hellwig D. Positron emission tomography 2008 in Germany – results of the query and current status. Nuklearmedizin 2010; 49: 58-64.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Salem N, Kuang Y, Wang F. et al. PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F] - fluoro-D-glucose, 6-deoxy-6[18F] fluoro-Dglucose, [1–11C]-acetate and [N-methyl-11C]-choline. Q J Nucl Med Mol Imaging 2009; 53: 144-156.
    PubMedGoogle Scholar
  • 7 Talbot JN, Fartoux L, Balogova S. et al. Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J Nucl Med 2010; 51: 1699-1706.
    CrossrefPubMedGoogle Scholar
  • 8 Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010; 15 (Suppl. 04) 5-13.
    CrossrefPubMedGoogle Scholar
  • 9 Vilgrain V. Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: hepatocellular carcinoma: imaging in assessing treatment efficacy. J Hepatobiliary Pancreat Sci 2010; 17: 374-379.
    CrossrefPubMedGoogle Scholar